Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention
- 1 June 2014
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 7 (6), 604-612
- https://doi.org/10.1016/j.jcin.2014.01.160
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary SyndromesThe New England Journal of Medicine, 2013
- American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular DeathCirculation, 2012
- Why all the struggle about CK-MB and PCI?European Heart Journal, 2012
- Periprocedural Myocardial InfarctionCirculation: Cardiovascular Interventions, 2010
- Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotectionEuropean Heart Journal, 2010
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trialThe Lancet, 2009
- Biomarker Release After Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2008
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2007
- Myocardial Reperfusion InjuryThe New England Journal of Medicine, 2007
- Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) studyAmerican Heart Journal, 2005